The Japan Society of Northern California is pleased to offer continuing programming that explores new dimensions of Japan – U.S. innovation and entrepreneurship. This “Innovation Salon”panel discussion will spotlight unique business opportunities and business models, arising from expansion of the UCSF Mission Bay complex - America’s center of biotechnology excellence - and reinforced by its very strong Japan ties.
- 5:30-6:15pm Registration & Early networking
- 6:20-6:40pm Comments from former US Ambassador John V. Roos
- 6:40-8:00pm Panel discussion
- 8:00-9:00pm Networking
- John V. Roos, former U.S. Ambassador to Japan
- Haru Morita, Chairman, President and Chief Executive Officer, REGIMMUNE Corporation, located in Santa Clara and Tokyo
- Douglas Crawford, Ph.D., Associate Director, California Institute for Quantitative Biosciences (QB3); & Managing Director, Mission Bay Capital.
- Mary Haak-Frendscho, Ph.D., Chief Executive Officer, Igenica, Inc.
- Robert Kneller, Professor, Research Center for Advanced Science and Technology (RCAST), University of Tokyo
5:30 – 6:15 pm
Registration & Early Bird Networking
6:15 – 6:17 pm
Welcoming Remarks by Nobuhiro Watanabe, Acting Consul General in San Francisco
6:17 – 6:45 pm
DISTINGUISHED ACCOMPLISHMENT AWARD to Ambassador John V. Roos
Presented by John R. Thomas, Chairman, Martingale Asset Management
Conversation: “The Entrepreneurial Climate in Japan”
John V. Roos, Former U.S. Ambassador to Japan
Discussion moderated by Robert Eberhart, Ph.D., Assistant Professor of Management, Santa Clara University
6:45 – 8:00 pm
CASE PRESENTATION, REMARKS and PANEL DISCUSSION
Highlighted Case: “Creating a Successful Japan – U.S. Biotech Business”
Haru Morita, Chairman, President and CEO, REGIMMUNE Corporation
Remarks: “Enabling Biotech Innovation and Entrepreneurship”
Douglas Crawford, Ph.D., Associate Director, California Institute for Quantitative Biosciences (QB3) and Managing Director, Mission Bay Capital
Remarks: “Building A Successful Biotech Career from the Bay Area”
Mary Haak-Frendscho, Ph.D., CEO, Igenica, Inc., and previously Founding President and Chief Scientific Officer, Takeda San Francisco
7:20 – 8:00 pm
Speaker Discussion and Audience Q&A
Discussion moderated by Robert Kneller, Professor, Research Center for Advanced Science and Technology (RCAST), University of Tokyo
8:00 – 9:00 pm
Hosted Reception (Complimentary Wine and Beer and hors d’ourves)
Attendees will gain invaluable insights into:
- QB3’s unique strategy to encourage pure bioscience research and facilitate the entrepreneurial development of that research
- REGIMMUNE’s distinctive business model that combines activities in both Japan and the U.S.
- Dr. Haak-Fredscho’s perspective about Japan – U.S. biotech business and career opportunities, shaped importantly through her current position and also having founded and led the San Francisco research presence of Takeda Pharmaceutical.
Time to also network!
- Wine and beer will be provided by the Japan Society of Northern California. This is a great opportunity to network with the speakers, innovators and entrepreneurs from the Bay Area with specific interests in biotechnology and life sciences.
By midnight Friday, September 20th:
- $15 per person for Japan Society Members & Students with ID
- $20 per person for Non-members
* No refunds after September 11th.
By 2:00 PM on Wednesday, September 25th:
- $20 per person for Japan Society Members & Students with ID
- $25 per person for Non-members
- $30 per person (cash or credit accepted at the door)
Please find the map to UCSF Mission Bay Genentech Hall below: